In summary, this study demonstrated that Vav3-mediated signaling converges with PI3K/Akt, ERK, and AR signaling pathways in support of the growth and survival of prostate cancer cells under chronic hypoxia. The gene discussed is VAV3; the disease is prostate cancer.